FDA Approves New Melanoma Treatment Yervoy
The FDA has approved Bristol-Myers' Yervoy for the treatment of late-stage, metastatic melanoma, a deadly skin cancer. The drug extends survival but does not cure the disease.
Click here to read the full story.
The content has been reported and it will be reviewed by a moderator.
